chartexchange

CME vs. Morningstar: Which Financial Stock Is a Better Buy for 2027?

The Motley Fool | Nov 16, 2026 6:36 AM EST

When choosing between exchange operators and data providers, do you prioritize massive profit margins or broad research influence? CME Group (NASDAQ:CME) and Morningstar (NASDAQ:MORN) offer two distinct paths for investors. CME Group provides the plumbing for global derivatives trading, while Morningstar serves as a trusted voice in investment research. Both companies benefit from the long-term growth of the financial markets, yet they operate with very different business models and capital structures. This comparison evaluates their financial health and risks to determine which is better for 2027. CME Group operates a global marketplace for derivatives, allowing participants to trade futures and options across major asset classes. As a leader among financial stocks , it partners with Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG) for technology infrastructure and Flutter Entertainment (NYSE:FLUT) for prediction market applications. One clearing firm accounted for nearly 12% of clearing and transaction fees in 2025, and customer concentration like this adds a layer of risk to the business. Continue reading

Read original article